Skip to Main Content

Paper Details

Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial.
Neuro Oncol
8
2022
CARBO, Carboplatin, ETMR, ETO, Embryonal Tumours, Embryonal tumours with multilayered rosettes, Etoposide, Multilayered Rosettes, PATIENTS, Patients, brainstem tumour, carboplatin, children, etoposide, patient, patients, tumours
Author NameAffiliation
Nicolas U GerberUniversity Children's Hospital Zurich
André O von BuerenUniversity Hospital of Geneva
Christine HaberlerMedical University of Vienna
Ulrich Sch??llerInstitute of Neuropathology, University Medical Centre Hamburg-Eppendorf and Research Institute Children's Cancer Center Hamburg
Stefan M PfisterHopp Children's Cancer Center (KITZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center (KITZ)
Stefan M PfisterGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Stefan M PfisterHeidelberg University Hospital
Torsten PietschInstitute of Neuropathology, University Hospital Bonn
Marcel KoolHopp Children's Cancer Center (KITZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Marcel KoolHopp Children's Cancer Center (KITZ)
Marcel KoolGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Stefan RutkowskiClinic for Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf
Stefan RutkowskiClinic for Paediatric Haematology and Oncology, University Medical Centre Hamburg-Eppendorf
Katja von HoffCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
  • 1 - 20

Datasets

Release 1.2